Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-24-049079

Chief Financial Officer bought 2,907.2 shares at $7.36 ($21,397)

From the SEC's structured data for this filing

Trades in this filing

Pamir Ozan · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-22 Purchase : show line 1 in the form +2,907.2 $7.36 $21,397 2,907.2 D
Open-market purchases · 2,907.2 sh · avg $7.36 · $21,397
Loading xslF345X05/wk-form4_1732537730.xml…